Literature DB >> 3367379

The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine.

C Ceconi1, S Curello, A Cargnoni, R Ferrari, A Albertini, O Visioli.   

Abstract

It is known that myocardial ischaemia causes a marked decline of cellular thiol pool and of protein sulphydryl groups content. Reperfusion under these conditions results in oxydative damage which is concomitant with poor recovery of mechanical function. We have evaluated the role of glutathione status in the protection against ischaemic and reperfusion damage by treating the isolated rabbit hearts with N-acetylcysteine (10(-6) M), a sulphydryl group donor. Ischaemic and reperfusion damage was determined in terms of mechanical function, rate of lactate and creatine kinase (CPK) release, mitochondrial function and tissue content of reduced (GSH) and oxidized (GSSG) glutathione and of protein sulphydryl groups (SH). After 60 mins of ischaemia (induced by reducing coronary flow from 24 to 1 ml/min) followed by 30 mins of reperfusion there was an increase of diastolic pressure to 51.6 +/- 3.5 mmHg with only a 22% recovery of systolic pressure, massive CPK release and a deterioration in mitochondrial function. Tissue contents of GSH and of protein SH were severely decreased, while those of GSSG were increased. The GSH/GSSG ratio was reduced from the aerobic value of 50 to 13.4, suggesting that an oxidative stress has occurred. N-acetylcysteine infused for 60 mins before ischaemia determined a 38% increase in tissue content of GSH with no major changes of GSSG or protein SH. The ischaemic-induced decrease of GSH and protein SH was also limited by pretreatment with N-acetylcysteine and there was no accumulation of GSSG after reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367379     DOI: 10.1016/s0022-2828(88)80174-3

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  36 in total

1.  Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.

Authors:  Pei-Suen Tsou; Nadine N Talia; Adam J Pinney; Ann Kendzicky; Sonsoles Piera-Velazquez; Sergio A Jimenez; James R Seibold; Kristine Phillips; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.

Authors:  R Ferrari; C Ceconi; A Cargnoni; E Pasini; G M Boffa; S Curello; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 3.  Cardiac mitochondria and arrhythmias.

Authors:  David A Brown; Brian O'Rourke
Journal:  Cardiovasc Res       Date:  2010-07-09       Impact factor: 10.787

4.  Lipid peroxidation during myocardial reperfusion.

Authors:  C Ceconi; A Cargnoni; E Pasini; E Condorelli; S Currello; R Ferrari
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

5.  Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.

Authors:  Suresh K Gupta; Amit Saxena; Uma Singh; Dharamvir S Arya
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

6.  Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillation.

Authors:  Catherine D E Wilder; Radwa Masoud; Duygu Yazar; Brett A O'Brien; Thomas R Eykyn; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2015-12-04       Impact factor: 8.739

7.  Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts.

Authors:  R Ferrari; A Cargnoni; S Curello; G M Boffa; C Ceconi
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization.

Authors:  David A Brown; Miguel A Aon; Chad R Frasier; Ruben C Sloan; Andrew H Maloney; Ethan J Anderson; Brian O'Rourke
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

Review 9.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

Review 10.  Stunning: a radical re-view.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.